These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27545090)

  • 1. Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer.
    Xia Q; Zhang FF; Geng F; Liu CL; Wang YQ; Xu P; Lu ZZ; Xie Y; Wu H; Chen Y; Zhang Y; Kong W; Yu XH; Zhang HH
    Cell Immunol; 2016 Dec; 310():89-98. PubMed ID: 27545090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice.
    Xia Q; Geng F; Zhang FF; Liu CL; Xu P; Lu ZZ; Zhang HH; Kong W; Yu XH
    Vaccine; 2016 Aug; 34(38):4526-4535. PubMed ID: 27498213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma.
    Xia Q; Geng F; Zhang FF; Liu CL; Xu P; Lu ZZ; Xie Y; Sun B; Wu H; Yu B; Kong W; Yu XH; Zhang HH
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):37-44. PubMed ID: 28004985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model.
    Xia Q; Zhang FF; Geng F; Liu CL; Xu P; Lu ZZ; Yu B; Wu H; Wu JX; Zhang HH; Kong W; Yu XH
    Cancer Immunol Immunother; 2016 May; 65(5):613-24. PubMed ID: 27020681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.
    Geng F; Guo J; Guo QQ; Xie Y; Dong L; Zhou Y; Liu CL; Yu B; Wu H; Wu JX; Zhang HH; Kong W; Yu XH
    Vaccine; 2019 Jul; 37(31):4382-4391. PubMed ID: 31202521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-based minigene vaccine targeting fibroblast activation protein α induces specific immune responses and anti-tumor effects in 4 T1 murine breast cancer model.
    Zhang FF; Qiao Y; Xie Y; Liu C; Wu H; Wu JX; Yu XH; Kong W; Zhang HH
    Int Immunopharmacol; 2022 Nov; 112():109237. PubMed ID: 36152535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.
    Meng M; Wang W; Yan J; Tan J; Liao L; Shi J; Wei C; Xie Y; Jin X; Yang L; Jin Q; Zhu H; Tan W; Yang F; Hou Z
    Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models.
    Chen M; Xu G; Fan M; Jia H; Xiao L; Lang J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4182-4193. PubMed ID: 31722575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts.
    Chen M; Xiang R; Wen Y; Xu G; Wang C; Luo S; Yin T; Wei X; Shao B; Liu N; Guo F; Li M; Zhang S; Li M; Ren K; Wang Y; Wei Y
    Sci Rep; 2015 Sep; 5():14421. PubMed ID: 26394925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model.
    Wen Y; Wang CT; Ma TT; Li ZY; Zhou LN; Mu B; Leng F; Shi HS; Li YO; Wei YQ
    Cancer Sci; 2010 Nov; 101(11):2325-32. PubMed ID: 20804499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice.
    Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB
    Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibroblast activation proteins-α suppress tumor immunity by regulating T cells and tumor-associated macrophages.
    Hou CM; Qu XM; Zhang J; Ding TT; Han W; Ji GC; Zhong ZH; Chen H; Zhang F
    Exp Mol Pathol; 2018 Feb; 104(1):29-37. PubMed ID: 29273462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
    Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
    Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
    Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
    Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
    Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
    Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
    Gottschalk S; Yu F; Ji M; Kakarla S; Song XT
    PLoS One; 2013; 8(12):e82658. PubMed ID: 24349329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
    Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
    J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.